Scarica l'app Stockscreener
3.09
9.96%
0.28
Dopo l'orario di chiusura:
2.89
-0.20
-6.47%
Psyence Biomedical Ltd Borsa (PBM) Ultime notizie
Why Psyence Biomedical Ltd. Equity Warrant stock could outperform in 2025Trade Risk Report & Fast Exit and Entry Trade Guides - mfd.ru
PsyLabs Secures Strategic Put Option Deal With Psyence BioMed to Scale Psychedelic API Manufacturing - TipRanks
Psyence Biomedical Ltd. Enters Put Option Agreement with PsyLabs to Strengthen Strategic Partnership in Psychedelic Manufacturing - Quiver Quantitative
Psyence, PsyLabs deal locks in psychedelic drug supply while preserving cash - Stock Titan
Psyence Biomedical Ratifies Put Option Deal With PsyLabs to Secure Psychedelic Supply - TipRanks
Psyence Biomedical Settles Shareholder Dispute With KAOS Capital - TipRanks
Activity Recap: How does Psyence Biomedical Ltd Equity Warrant perform in inflationary periodsIPO Watch & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Psyence Biomedical announces settlement of shareholder litigation - TipRanks
Psyence Biomed announces settlement of shareholder litigation - marketscreener.com
Psyence Biomedical Ltd. Reaches Settlement Agreement with KAOS Capital Ltd. to Resolve Shareholder Claims - Quiver Quantitative
Psyence BioMed Announces Settlement of Shareholder Litigation - ChartMill
Published on: 2026-02-11 15:38:29 - mfd.ru
Is Psyence Biomedical Ltd. stock forming a triangle patternWeekly Trend Recap & Risk Managed Investment Signals - mfd.ru
Revenue Check: Can Psyence Biomedical Ltd Equity Warrant beat the S P 500July 2025 Recap & Technical Pattern Recognition Alerts - baoquankhu1.vn
Aug Final Week: Is Xenon Pharmaceuticals Inc a play on infrastructure spendingBond Market & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Buy Signal: Will BMEA face regulatory challenges2025 Market Outlook & Weekly Watchlist of Top Performers - baoquankhu1.vn
Aug Sentiment: Whats the beta of Psyence Biomedical Ltd stock2025 Price Momentum & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Aug Breakouts: Is Psyence Biomedical Ltd. Equity Warrant forming a double bottomJuly 2025 Snapshot & Capital Efficiency Focused Ideas - baoquankhu1.vn
Will Psyence Biomedical Ltd. Equity Warrant benefit from government policyInsider Selling & Capital Protection Trading Alerts - mfd.ru
Analyst Calls: Will Psyence Biomedical Ltd benefit from rate cuts2025 Short Interest & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Psyence Biomedical Delays Reverse Stock Split Implementation - Intellectia AI
Quarterly Trades: Can Psyence Biomedical Ltd Equity Warrant outperform in the next rally2025 Market WrapUp & Reliable Price Action Trade Plans - baoquankhu1.vn
Growth Value: Is Psyence Biomedical Ltd Equity Warrant in a long term uptrendJuly 2025 Action & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Recap Report: How does Psyence Biomedical Ltd Equity Warrant perform in inflationary periodsJuly 2025 Update & Weekly High Return Opportunities - baoquankhu1.vn
Published on: 2026-01-31 23:30:18 - baoquankhu1.vn
Trend Recap: Will Psyence Biomedical Ltd Equity Warrant outperform tech stocksQuarterly Trade Report & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Downgrade Watch: Why Psyence Biomedical Ltd. Equity Warrant stock could outperform in 2025 - mfd.ru
Psyence Biomedical announces 1-for-6.25 share consolidation By Investing.com - Investing.com Australia
Will Psyence Biomedical Ltd. benefit from seasonalityTrade Risk Assessment & Reliable Entry Point Alerts - mfd.ru
What are the analyst revisions for NDRAIs Psyence Biomedical Ltd. stock a good investment in YEAR2025 Year in Review & Consistent Growth Equity Picks - mfd.ru
Psyence Biomedical Sets February 2 Effective Date for 1-for-6.25 Reverse Stock Split - TipRanks
Psyence BioMed (NASDAQ: PBM) plans 1-for-6.25 reverse stock split in 2026 - Stock Titan
Psyence Delays Effective Date For 1-for-6.25 Reverse Stock Split; Stock Down - Nasdaq
Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split - The Manila Times
Psyence Biomedical announces 1-for-6.25 share consolidation - Investing.com
Psyence Biomedical Ltd. Announces Delayed Implementation of 1-for-6.25 Share Consolidation Effective February 2, 2026 - Quiver Quantitative
Psyence Biomedical Reschedules Shareholder Meeting After Quorum Shortfall - TipRanks
Press Release: Psyence BioMed Announces Adjournment of Annual and Special Shareholder Meeting on January 22, 2026 - 富途牛牛
NEWCOURT ACQUISITION CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) - marketscreener.com
NEWCOURT ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - marketscreener.com
Psyence Biomedical announces milestone in natural ibogaine HCl production - MSN
Psyence BioMed Announces Adjournment of Annual and Special Shareholder Meeting on January 22, 2026 - The Manila Times
Psyence BioMed Announces Adjournment of Annual and Special Shareholder Meeting on January 22, 2026 - GlobeNewswire Inc.
Psyence Biomedical Calls January 22, 2026 Shareholder Meeting to Vote on Financials, Board and Share Consolidation - TipRanks
Psyence Biomedical sets Jan. 20 as effective date for reverse stock split - MSN
Psyence Biomedical postpones planned reverse stock split By Investing.com - Investing.com South Africa
Psyence Biomedical announces postponement of reverse stock split effective date - TipRanks
Psyence Biomedical postpones planned reverse stock split - Investing.com
Psyence Biomedical Ltd. Announces Postponement of Reverse Stock Split Effective Date - Quiver Quantitative
Psyence BioMed Announces Postponement of Previously Announced Reverse Stock Split Effective Date - GlobeNewswire
Why Psyence Biomedical Ltd. stock could benefit from AI revolutionConsumer Goods Stocks & Free Powerful Profit Generation - Bollywood Helpline
Can Psyence Biomedical Ltd. outperform in the next rally2025 Volatility Report & Weekly Watchlist for Consistent Profits - bollywoodhelpline.com
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):